Literature DB >> 33538649

Implementation of a Mobile Health Strategy to Improve Linkage to and Engagement with HIV Care for People Living with HIV, Tuberculosis, and Substance Use in Irkutsk, Siberia.

Jacqueline Hodges1, Svetlana Zhdanova2, Olga Koshkina3, Alexey Suzdalnitsky3, Ava Lena Waldman1, Jason Schwendinger1, Serhiy Vitko1, Alexey Plenskey4, Yulia Plotnikova4, Elena Moiseeva3, Mikhail Koshcheyev3, Sergey Sebekin4, Oleg Ogarkov2, Rebecca Dillingham1, Scott Heysell1.   

Abstract

In Irkutsk, Siberia, there is a high prevalence of HIV and tuberculosis (TB) coinfection. Mobile health (mHealth) strategies have shown promise for increasing linkage to and engagement in care for people living with HIV (PLWH) in other contexts. We evaluated outcomes for a cohort of PLWH, TB, and substance use in Irkutsk after participation in a multi-feature mHealth intervention called MOCT. Sixty patients were enrolled during hospitalization for TB. We evaluated participant app usage, linkage to HIV care postdischarge, perception of self-efficacy related to HIV care, and HIV-related clinical outcomes at 6 months. We also performed an exploratory analysis to compare a subset of 49 patients with a pre-intervention cohort matched for age and gender. Participants demonstrated engagement with app features examined at 6 months. The majority linked to HIV care by 6 months (83%). Self-scoring of confidence in ability to communicate with HIV providers improved from baseline (median score 8, scale 1-10) to 6 months (10, p = 0.004). A higher proportion of the MOCT subset refilled antiretroviral therapy (69% vs. 43% in pre-intervention cohort, p = 0.01), with fewer deaths in the MOCT subset at 6 months (1 death vs. 10 deaths in pre-intervention cohort, p = 0.02) and a decreased likelihood of developing the composite outcome of death/failure to achieve viral suppression at 6 months (adjusted odds ratio = 0.33, p = 0.029). This study demonstrates preliminary intervention uptake and improvement in short-term outcomes for an urban cohort of PLWH, TB, and substance use enrolled in a multi-feature mHealth intervention, a novel strategy for the context. Clinical Trial Registration Number: NCT03819374.

Entities:  

Keywords:  acquired immunodeficiency syndrome; human immunodeficiency virus; linkage to care; mobile health; tuberculosis

Mesh:

Year:  2021        PMID: 33538649      PMCID: PMC7987354          DOI: 10.1089/apc.2020.0233

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  18 in total

Review 1.  Getting to grips with the HIV epidemic in Russia.

Authors:  Raminta Stuikyte; Isabela Barbosa; Michel Kazatchkine
Journal:  Curr Opin HIV AIDS       Date:  2019-09       Impact factor: 4.283

2.  A Systematic Review of Mobile Phone Interventions (SMS/IVR/Calls) to Improve Adherence and Retention to Antiretroviral Treatment in Low-and Middle-Income Countries.

Authors:  Binyam Afewerk Demena; Luis Artavia-Mora; Dénis Ouedraogo; Boundia Alexandre Thiombiano; Natascha Wagner
Journal:  AIDS Patient Care STDS       Date:  2020-02       Impact factor: 5.078

3.  Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia.

Authors:  Robert Heimer; Nina Usacheva; Russell Barbour; Linda M Niccolai; Anneli Uusküla; Olga S Levina
Journal:  Addiction       Date:  2017-05-04       Impact factor: 6.526

4.  Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.

Authors:  S K Heysell; O B Ogarkov; S Zhdanova; E Zorkaltseva; S Shugaeva; J Gratz; S Vitko; E D Savilov; M E Koshcheyev; E R Houpt
Journal:  Int J Tuberc Lung Dis       Date:  2016-02       Impact factor: 2.373

5.  Administrative interventions associated with increased initiation on antiretroviral therapy in Irkutsk, Siberia.

Authors:  O B Ogarkov; A Ebers; S Zhdanova; E Moiseeva; M E Koshcheyev; E Zorkaltseva; S Shugaeva; S Vitko; G Lyles; E R Houpt; S K Heysell
Journal:  Public Health Action       Date:  2016-12-21

Review 6.  Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Shipeng Yan; Lizhang Chen; Wenqiong Wu; Zhongxi Fu; Heng Zhang; Zhanzhan Li; Chenchao Fu; Jingsong Mou; Jing Xue; Yingyun Hu
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

Review 7.  mHealth Interventions To Support Self-Management In HIV: A Systematic Review.

Authors:  Vanessa Cooper; Jane Clatworthy; Jennifer Whetham; EmERGE Consortium
Journal:  Open AIDS J       Date:  2017-11-21

Review 8.  mHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative Review.

Authors:  Stephen B Lee; Joanne Valerius
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-28       Impact factor: 4.773

9.  Toward understanding the impact of mHealth features for people with HIV: a latent class analysis of PositiveLinks usage.

Authors:  Chelsea E Canan; Tabor E Flickinger; Marika Waselewski; Alexa Tabackman; Logan Baker; Samuel Eger; Ava Lena D Waldman; Karen Ingersoll; Rebecca Dillingham
Journal:  Transl Behav Med       Date:  2021-02-11       Impact factor: 3.046

10.  Targeted client communication via mobile devices for improving maternal, neonatal, and child health.

Authors:  Melissa J Palmer; Nicholas Henschke; Hanna Bergman; Gemma Villanueva; Nicola Maayan; Tigest Tamrat; Garrett L Mehl; Claire Glenton; Simon Lewin; Marita S Fønhus; Caroline Free
Journal:  Cochrane Database Syst Rev       Date:  2020-07-14
View more
  1 in total

1.  Process evaluation for the adaptation, testing and dissemination of a mobile health platform to support people with HIV and tuberculosis in Irkutsk, Siberia.

Authors:  Jacqueline Hodges; Ava Lena Waldman; Olga Koshkina; Alexey Suzdalnitsky; Jason Schwendinger; Serhiy Vitko; Alexey Plenskey; Yulia Plotnikova; Elena Moiseeva; Mikhail Koshcheyev; Sergey Sebekin; Svetlana Zhdanova; Oleg Ogarkov; Scott Heysell; Rebecca Dillingham
Journal:  BMJ Open       Date:  2022-03-29       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.